Stay updated on HPN217 in R/R MM: Safety, PK, Clinical Trial
Sign up to get notified when there's something new on the HPN217 in R/R MM: Safety, PK, Clinical Trial page.

Latest updates to the HPN217 in R/R MM: Safety, PK, Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNo substantive changes detected in the Study Details; the new screenshot appears to show only minor formatting updates and a refreshed last update timestamp rather than changes to eligibility criteria, study locations, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoNo Change Detected
- Check42 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference2%

- Check49 days agoChange DetectedTerminology changed from Plasma cell myeloma to Multiple myeloma and the page version updated to v3.1.0.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1; the Back to Top element has been removed, indicating a minor UI cleanup alongside the version update.SummaryDifference0.1%

- Check71 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check78 days agoChange DetectedThe web page has undergone significant changes, including the removal of specific location details and the deletion of references to Multiple Myeloma, while adding new information about Plasma cell myeloma and Hemic and Lymphatic Diseases.SummaryDifference1%

Stay in the know with updates to HPN217 in R/R MM: Safety, PK, Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HPN217 in R/R MM: Safety, PK, Clinical Trial page.